Top 10 bbt.mediaroom.com Competitors

investor.baxter.com

Accelerates the company’s vision for transforming healthcare and advancing patient care worldwide – from the hospital to the home Combination creates opportunities for innovation that should drive efficiencies across care settings and help improve care outcomes Complementary products and pipeline enable broader access to care globally Expected to generate high single-digit ROIC by year five and approximately $250 million of annual pre-tax cost synergies by the end of year three Positions Baxter for anticipated faster top- and bottom-line growth Baxter International Inc. (NYSE:BAX), a global medtech leader, announced today it has completed its acquisition of Hillrom. Baxter paid $156.00 in cash for each outstanding share of Hillrom common stock for a purchase price of $10.5 billion (based on Hillrom share counts at closing). Including the assumption of Hillrom’s outstanding debt obligations, the enterprise value of the transaction is approximately $12.5 billion. “The Baxter-Hillrom